These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 32440910)
1. EGFR Targeted Paclitaxel and Piperine Co-loaded Liposomes for the Treatment of Triple Negative Breast Cancer. Burande AS; Viswanadh MK; Jha A; Mehata AK; Shaik A; Agrawal N; Poddar S; Mahto SK; Muthu MS AAPS PharmSciTech; 2020 May; 21(5):151. PubMed ID: 32440910 [TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of piperine and paclitaxel on cell fate via cyt-c, Bax/Bcl-2-caspase-3 pathway in ovarian adenocarcinomas SKOV-3 cells. Pal MK; Jaiswar SP; Srivastav AK; Goyal S; Dwivedi A; Verma A; Singh J; Pathak AK; Sankhwar PL; Ray RS Eur J Pharmacol; 2016 Nov; 791():751-762. PubMed ID: 27756602 [TBL] [Abstract][Full Text] [Related]
3. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite. Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004 [TBL] [Abstract][Full Text] [Related]
4. Unfolding the Potency of Adenosine in Targeting Triple Negative Breast Cancer via Paclitaxel-Incorporated pH-Responsive Stealth Liposomes. Chaudhari D; Katari O; Ghadi R; Kuche K; Date T; Bhargavi N; Jain S ACS Biomater Sci Eng; 2022 Aug; 8(8):3473-3484. PubMed ID: 35896042 [TBL] [Abstract][Full Text] [Related]
6. PEGylated pH-Responsive Liposomes for Enhancing the Intracellular Uptake and Cytotoxicity of Paclitaxel in MCF-7 Breast Cancer Cells. Nijhawan HP; Shyamsundar P; Prabhakar B; Yadav KS AAPS PharmSciTech; 2024 Sep; 25(7):216. PubMed ID: 39289249 [TBL] [Abstract][Full Text] [Related]
7. Paclitaxel/epigallocatechin gallate coloaded liposome: a synergistic delivery to control the invasiveness of MDA-MB-231 breast cancer cells. Ramadass SK; Anantharaman NV; Subramanian S; Sivasubramanian S; Madhan B Colloids Surf B Biointerfaces; 2015 Jan; 125():65-72. PubMed ID: 25437065 [TBL] [Abstract][Full Text] [Related]
8. Piperine and Celecoxib synergistically inhibit colon cancer cell proliferation via modulating Wnt/β-catenin signaling pathway. Srivastava S; Dewangan J; Mishra S; Divakar A; Chaturvedi S; Wahajuddin M; Kumar S; Rath SK Phytomedicine; 2021 Apr; 84():153484. PubMed ID: 33667839 [TBL] [Abstract][Full Text] [Related]
9. Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy. Haney MJ; Zhao Y; Jin YS; Li SM; Bago JR; Klyachko NL; Kabanov AV; Batrakova EV J Neuroimmune Pharmacol; 2020 Sep; 15(3):487-500. PubMed ID: 31722094 [TBL] [Abstract][Full Text] [Related]
10. Hesperidin, piperine and bee venom synergistically potentiate the anticancer effect of tamoxifen against breast cancer cells. Khamis AAA; Ali EMM; El-Moneim MAA; Abd-Alhaseeb MM; El-Magd MA; Salim EI Biomed Pharmacother; 2018 Sep; 105():1335-1343. PubMed ID: 30021371 [TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of a novel drug delivery: Soluplus Ding Y; Wang C; Wang Y; Xu Y; Zhao J; Gao M; Ding Y; Peng J; Li L Drug Dev Ind Pharm; 2018 Sep; 44(9):1409-1416. PubMed ID: 29718714 [TBL] [Abstract][Full Text] [Related]
12. CDK2 and Bcl-xL inhibitory mechanisms by docking simulations and anti-tumor activity from piperine enriched supercritical extract. Grinevicius VMAS; Andrade KS; Mota NSRS; Bretanha LC; Felipe KB; Ferreira SRS; Pedrosa RC Food Chem Toxicol; 2019 Oct; 132():110644. PubMed ID: 31252023 [TBL] [Abstract][Full Text] [Related]
14. Piperine enhances the efficacy of TRAIL-based therapy for triple-negative breast cancer cells. Abdelhamed S; Yokoyama S; Refaat A; Ogura K; Yagita H; Awale S; Saiki I Anticancer Res; 2014 Apr; 34(4):1893-9. PubMed ID: 24692724 [TBL] [Abstract][Full Text] [Related]
15. Piperine enhances doxorubicin sensitivity in triple-negative breast cancer by targeting the PI3K/Akt/mTOR pathway and cancer stem cells. Hakeem AN; El-Kersh DM; Hammam O; Elhosseiny A; Zaki A; Kamel K; Yasser L; Barsom M; Ahmed M; Gamal M; Attia YM Sci Rep; 2024 Aug; 14(1):18181. PubMed ID: 39107323 [TBL] [Abstract][Full Text] [Related]
16. Investigation of the antibacterial activity and efflux pump inhibitory effect of co-loaded piperine and gentamicin nanoliposomes in methicillin-resistant Staphylococcus aureus. Khameneh B; Iranshahy M; Ghandadi M; Ghoochi Atashbeyk D; Fazly Bazzaz BS; Iranshahi M Drug Dev Ind Pharm; 2015 Jun; 41(6):989-94. PubMed ID: 24842547 [TBL] [Abstract][Full Text] [Related]
17. Piperine inhibits the growth and motility of triple-negative breast cancer cells. Greenshields AL; Doucette CD; Sutton KM; Madera L; Annan H; Yaffe PB; Knickle AF; Dong Z; Hoskin DW Cancer Lett; 2015 Feb; 357(1):129-140. PubMed ID: 25444919 [TBL] [Abstract][Full Text] [Related]
18. Fmoc-conjugated PEG-vitamin E2 micelles for tumor-targeted delivery of paclitaxel: enhanced drug-carrier interaction and loading capacity. Zhang Y; Huang Y; Zhao W; Lu J; Zhang P; Zhang X; Li J; Gao X; Venkataramanan R; Li S AAPS J; 2014 Nov; 16(6):1282-91. PubMed ID: 25193267 [TBL] [Abstract][Full Text] [Related]
19. Co-delivery of rapamycin- and piperine-loaded polymeric nanoparticles for breast cancer treatment. Katiyar SS; Muntimadugu E; Rafeeqi TA; Domb AJ; Khan W Drug Deliv; 2016 Sep; 23(7):2608-2616. PubMed ID: 26036652 [TBL] [Abstract][Full Text] [Related]
20. Surface modification of paclitaxel-loaded liposomes using d-α-tocopheryl polyethylene glycol 1000 succinate: Enhanced cellular uptake and cytotoxicity in multidrug resistant breast cancer cells. Han SM; Baek JS; Kim MS; Hwang SJ; Cho CW Chem Phys Lipids; 2018 Jul; 213():39-47. PubMed ID: 29550143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]